SCOPUS 정보 검색 플랫폼

Blood Cells, Molecules, and Diseases

Volumn 46, Issue 1, 2011, Pages 105-106

Short-term withdrawal from imiglucerase: What can we learn from it?

(1) Hollak, Carla E M a

a ACADEMIC MEDICAL CENTER (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHITOTRIOSIDASE; IMIGLUCERASE; MIGLUSTAT; TALIGLUCERASE ALFA; UNCLASSIFIED DRUG; UPYLSO; VELAGLUCERASE ALFA;

BLEEDING; BONE PAIN; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENZYME REPLACEMENT; EPISTAXIS; FATIGUE; FRACTURE; GAUCHER DISEASE; LOW DRUG DOSE; MAINTENANCE THERAPY; NOTE; PATIENT COMPLIANCE; PRIORITY JOURNAL; THROMBOCYTE COUNT;

ENZYME REPLACEMENT THERAPY; GAUCHER DISEASE; GLUCOSYLCERAMIDASE; HUMANS; PATIENT CARE PLANNING; TIME FACTORS;

EID: 78049506152 PISSN: 10799796 EISSN: None Source Type: Journal
DOI: 10.1016/j.bcmd.2010.05.003 Document Type: Note

Times cited : (5)

References (8)

1
- 0034932001
- Clinical monitoring after cessation of enzyme replacement therapy in M. Gaucher
- vom Dahl S., Poll L.W., Haussinger D. Clinical monitoring after cessation of enzyme replacement therapy in M. Gaucher. Br. J. Haematol. 2001, 113:1084-1087.
- (2001) Br. J. Haematol. , vol.113 , pp. 1084-1087
- vom Dahl, S.¹ Poll, L.W.² Haussinger, D.³

2
- 0013117809
- Cessation of enzyme replacement therapy in Gaucher disease
- Grinzaid K.A., Geller E., Hanna S.L., Elsas L.J. Cessation of enzyme replacement therapy in Gaucher disease. Genet. Med. 2002, 4:427-433.
- (2002) Genet. Med. , vol.4 , pp. 427-433
- Grinzaid, K.A.¹ Geller, E.² Hanna, S.L.³ Elsas, L.J.⁴

3
- 34447507878
- Clinical consequences of interrupting enzyme replacement therapy in children with type 1 Gaucher disease
- Drelichman G., Ponce E., Basack N., et al. Clinical consequences of interrupting enzyme replacement therapy in children with type 1 Gaucher disease. J. Pediatr. 2007, 151:197-201.
- (2007) J. Pediatr. , vol.151 , pp. 197-201
- Drelichman, G.¹ Ponce, E.² Basack, N.³

4
- 0033836414
- Withdrawal of enzyme replacement therapy in Gaucher disease
- Elstein D., Abrahamov A., Hadas-Halpern I., Zimran A. Withdrawal of enzyme replacement therapy in Gaucher disease. Br. J. Haematol. 2000, 110:488-492.
- (2000) Br. J. Haematol. , vol.110 , pp. 488-492
- Elstein, D.¹ Abrahamov, A.² Hadas-Halpern, I.³ Zimran, A.⁴

5
- 73049102077
- Force majeure: therapeutic measures in response to restricted supply of imiglucerase (Cerezyme) for patients with Gaucher disease
- Hollak C.E., Vom Dahl S., Aerts J.M., et al. Force majeure: therapeutic measures in response to restricted supply of imiglucerase (Cerezyme) for patients with Gaucher disease. Blood Cells Mol. Dis. 2010, 44:41-47.
- (2010) Blood Cells Mol. Dis. , vol.44 , pp. 41-47
- Hollak, C.E.¹ Vom Dahl, S.² Aerts, J.M.³

6
- 84855617944
- Enzyme replacement therapy "drug holiday": results from an unexpected shortage of an orphan drug supply in Australia
- Goldblatt J., Fletcher J.M., McGill J., Szer J., Wilson M. Enzyme replacement therapy "drug holiday": results from an unexpected shortage of an orphan drug supply in Australia. Blood Cells Mol. Dis. 2010.
- (2010) Blood Cells Mol. Dis.
- Goldblatt, J.¹ Fletcher, J.M.² McGill, J.³ Szer, J.⁴ Wilson, M.⁵

7
- 78049493644
- Non-precipitous changes upon withdrawal from imiglucerase for Gaucher disease because of a shortage in supply
- Zimran A., Altarescu G., Elstein D. Non-precipitous changes upon withdrawal from imiglucerase for Gaucher disease because of a shortage in supply. Blood Cells Mol. Dis. 2010.
- (2010) Blood Cells Mol. Dis.
- Zimran, A.¹ Altarescu, G.² Elstein, D.³

8
- 78650826917
- Press release Genzyme, April 21,. Ref Type: Internet Communication.
- Press release Genzyme, April 21, 2010. Ref Type: Internet Communication.
- (2010)

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.